Search

Displaying results 7121 - 7130 of 10000 in total
  1. Drug

    Formebolone

    go.drugbank.com/drugs/DB01569
    IllicitInvestigational

    Formebolone, a derivative of androstane, is an anabolic androgenic steroid. It is on the list of substances prohibited by the Word Anti-Doping Agency, and is regularly screened for in athletes. … [A14416] It is also classified by the US Drug Enforcement Administration as Schedule III drug in the Controlled Substances Act.

  2. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  3. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  4. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  5. Drug

    Triphendiol

    go.drugbank.com/drugs/DB06588
    Experimental

  6. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  7. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  8. Drug

    Vabametkib

    go.drugbank.com/drugs/DB21629
    Investigational

    Vabametkib is a small molecule drug. … Vabametkib is under investigation in clinical trial NCT05541822 (To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET

  9. Drug

    Cenacitinib

    go.drugbank.com/drugs/DB21735
    Investigational

    Cenacitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Cenacitinib is a Janus kinase inhibitor. … Cenacitinib is under investigation in clinical trial NCT05688852 (VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease).

  10. Drug

    Butaperazine

    go.drugbank.com/drugs/DB13213
    Approved

    Butaperazine was approved in 1967 [L5143], and possibly discontinued in the 1980s [T397].